Chengdu Easton Biopharmaceuticals Co., Ltd. (SHA:688513)
China flag China · Delayed Price · Currency is CNY
64.39
-2.12 (-3.19%)
Feb 13, 2026, 3:00 PM CST

SHA:688513 Balance Sheet

Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2024FY 2023FY 2022FY 2021FY 2020
Period Ending
Sep '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20
Cash & Equivalents
584.41971.4781.23830.971,0511,055
Trading Asset Securities
981.76452.35741.78516.36453.84570
Cash & Short-Term Investments
1,5661,4241,5231,3471,5051,625
Cash Growth
11.14%-6.52%13.04%-10.45%-7.43%302.24%
Accounts Receivable
257.32288.44177.7180.92126.73151.12
Other Receivables
0.530.440.661.250.170.42
Receivables
257.85288.88178.36182.17126.9151.53
Inventory
224.83190.09160.98140.87103.6884.03
Prepaid Expenses
-4.224.112.783.25.31
Other Current Assets
26.3221.7616.4125.9740.7627.78
Total Current Assets
2,0751,9291,8831,7091,7791,894
Property, Plant & Equipment
1,2261,2491,2551,141874.59571.68
Long-Term Investments
99.5580.7181.0846.66--
Other Intangible Assets
33.8135.634.4634.6133.7134.22
Long-Term Deferred Tax Assets
12.8611.58.578.7312.168.73
Long-Term Deferred Charges
89.4877.5154.9245.3612.353.42
Other Long-Term Assets
22.1716.7329.8932.0963.3918.87
Total Assets
3,5593,4003,3473,0182,7752,531
Accounts Payable
141.91144.35180.94156.86203.92122.73
Accrued Expenses
37.61266.85218.97190.72156.1161.12
Short-Term Debt
95.0874.44180.95105.2920.0240.03
Current Portion of Long-Term Debt
4.43.672.93---
Current Income Taxes Payable
37.944.623.341.462.714.96
Current Unearned Revenue
27.6638.2831.9828.7110.9916.47
Other Current Liabilities
248.6864.1241.9846.3538.7239.97
Total Current Liabilities
593.27596.32661.09529.39432.46385.28
Long-Term Debt
33.7535.9339.6---
Long-Term Unearned Revenue
63.0268.2541.1842.8151.0350.33
Long-Term Deferred Tax Liabilities
2.91.71.460.880.12-
Total Liabilities
692.94702.21743.33573.08483.6435.61
Common Stock
176.53176.53120.09120.09120.09120.09
Additional Paid-In Capital
1,4001,3881,4441,4441,4441,444
Retained Earnings
1,3551,2081,040880.3727.45531.05
Treasury Stock
-67.67-76.22-1.59---
Comprehensive Income & Other
2.191.020.990.020.070.06
Shareholders' Equity
2,8662,6982,6032,4442,2922,095
Total Liabilities & Equity
3,5593,4003,3473,0182,7752,531
Total Debt
133.23114.04223.48105.2920.0240.03
Net Cash (Debt)
1,4331,3101,3001,2421,4851,585
Net Cash Growth
15.35%0.78%4.63%-16.33%-6.35%296.95%
Net Cash Per Share
8.147.487.347.038.4310.77
Filing Date Shares Outstanding
174.35174.08174.93176.53176.53176.53
Total Common Shares Outstanding
174.35174.08176.49176.53176.53176.53
Working Capital
1,4821,3321,2221,1801,3471,509
Book Value Per Share
16.4415.5014.7513.8512.9811.87
Tangible Book Value
2,8322,6622,5692,4102,2582,061
Tangible Book Value Per Share
16.2415.2914.5613.6512.7911.68
Buildings
-775.81724.27487.54152.45140.27
Machinery
-678.03661.8673.35279.81226.86
Construction In Progress
-189.56186.26231.12637.88372.73
Updated Sep 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.